To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Getting Innovations to Patients During Shutdowns Act. H.R. 9635. 119th
Cong., 2nd
sess., Introduced in House July 9, 2026. https://www.govinfo.gov/app/details/BILLS-119hr9635ih.
APA
Congress, House of Representatives (2026, July 9). Getting Innovations to Patients During Shutdowns Act (H.R. 9635 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr9635ih.
MLA
United States, Congress, House of Representatives. Getting Innovations to Patients During Shutdowns Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr9635ih. 119th Congress, H.R. 9635, Introduced in House 9 Jul. 2026.
Bluebook
H.R.9635 - 119th Congress (2025-2026): Getting Innovations to Patients During Shutdowns Act, H.R.9635, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr9635ih.
